Journal Browser Advanced Search Help
Journal Browser Advanced search HELP
World J Mens Health. 2016 Aug;34(2):89-100. English. Review. https://doi.org/10.5534/wjmh.2016.34.2.89
DeLay KJ , Haney N , Hellstrom WJ .
Department of Urology, Tulane University School of Medicine, New Orleans, LA, USA. whellst@tulane.edu
Abstract

Erectile dysfunction (ED) is prevalent among men and its presence is often an indicator of systemic disease. Risk factors for ED include cardiovascular disease, hypertension, diabetes mellitus (DM), tobacco use, hyperlipidemia, hypogonadism, lower urinary tract symptoms, metabolic syndrome, and depression. Addressing the modifiable risk factors frequently improves a patient's overall health and increases lifespan. The literature suggests that smoking cessation, treatment of hyperlipidemia, and increasing physical activity will improve erectile function in many patients. How the treatment of DM, depression, and hypogonadism impacts erectile function is less clear. Clinicians need to be aware that certain antihypertensive agents can adversely impact erectile function. The treatment of men with ED needs to address the underlying risk factors to ameliorate the disease process.

Copyright © 2019. Korean Association of Medical Journal Editors.